Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China harmonization

This article was originally published in The Gray Sheet

Executive Summary

The Chinese State Drug Administration (SDA) will meet with two FDA officials and three industry representatives from U.S. and European device trade organizations at a Sept. 11-13 workshop in Kunming to help familiarize Chinese SDA officials with Global Harmonization Task Force quality systems regulations. Postmarket surveillance and use of standards are among other items on the agenda. Sponsored by the U.S. Department of Commerce, the workshop stems from an April meeting with SDA by the U.S. Joint Commission on Commerce and Trade/Medical & Pharmaceutical subgroup to China (1"The Gray Sheet" May 21, 2001, p. 8). Commerce hopes that the workshop will encourage China to harmonize, cutting barriers and stimulating medical device trade

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel